Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Expert Opinion on Drug Discovery|June 29, 2019
How do we choose the appropriate animal model for antiseizure therapy development?Melissa Barker-HaliskiJournal of Alzheimer'S Disease : JAD|January 9, 2025
Seizing the opportunity to therapeutically address neuronal hyperexcitability in Alzheimer's diseaseMelissa Barker-HaliskiExpert Opinion on Drug Discovery|July 30, 2024
Innovative drug discovery strategies in epilepsy: integrating next-generation syndrome-specific mouse models to address pharmacoresistance and epileptogenesisMelissa Barker-Haliski, Nicole A HawkinsThe International Journal of Pharmacy Practice|October 29, 2025
Multicompartment compliance aids: scoping barriers to their use in practiceMelissa Barker, Selina Taylor, Beverley GlassExperimental Neurology|December 6, 2022
Cannabidiol reveals a disruptive strategy for 21st century epilepsy drug discoveryAaron Del Pozo, Melissa Barker-HaliskiFrontiers in Neurology|August 18, 2023
Loss of normal Alzheimer's disease-associated Presenilin 2 function alters antiseizure medicine potency and tolerability in the 6-Hz focal seizure modelLeanne M Lehmann, Melissa Barker-HaliskiCold Spring Harbor Perspectives in Medicine|June 24, 2015
Glutamatergic Mechanisms Associated with Seizures and EpilepsyMelissa Barker-Haliski, H Steve WhiteNeuropharmacology|August 31, 2019
Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screeningMelissa Barker-Haliski, H Steve WhiteInternational Journal of Molecular Sciences|March 11, 2023
Frontline Sodium Channel-Blocking Antiseizure Medicine Use Promotes Future Onset of Drug-Resistant Chronic SeizuresDannielle Zierath, Stephanie Mizuno, Melissa Barker-HaliskiExpert Review of Anticancer Therapy|August 26, 2003
Peutz-Jeghers syndrome: genetic screeningBarbara A Leggett, Joanne P Young, Melissa BarkerPageof 7